621: The CFO as Science Enabler | Ivor Macleod, CFO, Athersys
When veteran CFO Ivor Macleod first contemplated joining an early-stage pharma company, the condition known as acute respiratory distress syndrome (ARDS) was not appearing in nightly news headlines and was yet to be ranked as the number one cause of death among COVID-19 patients. Nevertheless, ARDS captured his attention—or rather, Athersys did.
The Cleveland, Ohio–based company, with fewer than 100 employees, met one of Macleod’s foremost criteria in that the company was focused on the area of medicine known as “critical care”—a space that Macleod characterizes as having “high unmet medical…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.